Array comparative genomic hybridization in osteosarcoma

Methods in Molecular Biology

Volumn 973, Issue , 2013, Pages 227-247

  Sadikovic, Bekim ^a   Park, Paul C ^a   Selvarajah, Shamini ^a   Zielenska, Maria ^a  

^a NONE

Author keywords

ACGH; Array comparative genomic hybridization; Copy number; Genomic instability; Genomic integration; Integrative analysis; Osteosarcoma; RUNX2

Indexed keywords

ANALYTIC METHOD; ARRAY COMPARATIVE GENOMIC HYBRIDIZATION; ARTICLE; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DATA ANALYSIS; GENOMICS; HUMAN; MEDICAL LITERATURE; OSTEOSARCOMA; PRIORITY JOURNAL; ANIMAL; GENE DOSAGE; GENETICS; GENOMIC INSTABILITY; METHODOLOGY; REVIEW;

TRANSCRIPTION FACTOR RUNX2;

ANIMALS; COMPARATIVE GENOMIC HYBRIDIZATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE DOSAGE; GENOMIC INSTABILITY; HUMANS; OSTEOSARCOMA;

MLCS; MLOWN;

EID: 84880830776     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-281-0_15     Document Type: Article

References (83)

1. Skubitz KM, D'adamo DR (2007) Sarcoma. Mayo Clin Proc 82(11): 1409-1432
2. Horvai A, Unni K.K. (2006) Premalignant conditions of bone. J Orthop Sci 11(4): 412-423. doi: 10.1007/s00776-006-1037-6
3. Kansara M, Thomas D.M. (2007) Molecular pathogenesis of osteosarcoma. DNA Cell Biol 26(1): 1-18. doi: 10.1089/dna.2006.0505
4. Rozeman LB, Cleton-Jansen AM, Hogendoorn P.C. (2006) Pathology of primary malignant bone and cartilage tumours. Int Orthop 30(6): 437-444. doi: 10.1007/s00264-006-0212-x
5. Dick DC, Morley WN, Watson J.T. (1982) Rothmund-thomson syndrome and osteogenic sarcoma. Clin Exp Dermatol 7(1): 119-123
6. White LM, Kandel R. (2000) Osteoid-producing tumors of bone. Semin Musculoskelet Radiol 4(1): 25-43. doi: smr00105 [pii]
7. Klein MJ, Siegal G.P. (2006) Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol 125(4): 555-581. doi: UC6KQHLD9LV2KENN [pii] 10.1309/UC6K-QHLD-9LV2-KENN
8. Hauben EI, Weeden S, Pringle J et al (2002) Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the european osteosarcoma intergroup. Eur J Cancer 38(9): 1218-1225. doi: S0959804902000370 [pii]
9. Bielack SS, Kempf-Bielack B, Delling G et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20(3): 776-790
10. Posthumadeboer J, Witlox MA, Kaspers GJ et al (2011) Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature. Clin Exp Metastasis 28(5): 493-503. doi: 10.1007/s10585-011-9384-x
11. Fabbro D, Ruetz S, Buchdunger E et al (2002) Protein kinases as targets for anticancer agents: from inhibitors to useful drugs. Pharmacol Ther 93(2-3): 79-98. doi: S0163725802001791 [pii]
12. Mcgary EC, Weber K, Mills L et al (2002) Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor sti571. Clin Cancer Res 8(11): 3584-3591
13. Khanna C, Wan X, Bose S et al (2004) The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10(2): 182-186. doi: 10.1038/nm982nm982 [pii]
14. Al-Romaih K., Somers GR, Bayani J et al (2007) Modulation by decitabine of gene expression and growth of osteosarcoma u2os cells in vitro and in xenografts: Identification of apoptotic genes as targets for demethylation. Cancer cell Int 7: 14
15. Selvarajah S, Yoshimoto M, Ludkovski O et al (2008) Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array cgh and interphase fish. Cytogenet Genome Res 122(1): 5-15. doi: 000151310 [pii] 10.1159/000151310
16. Nowak NJ, Miecznikowski J, Moore SR et al (2007) Challenges in array comparative genomic hybridization for the analysis of cancer samples. Genet Med 9(9): 585-595. doi: 10.1097/GIM.0b013e3181461c4a00125817-200709000-00005 [pii]
17. Pugh TJ, Delaney AD, Farnoud N et al (2008) Impact of whole genome amplification on analysis of copy number variants. Nucleic Acids Res 36(13): e80. doi: gkn378 [pii] 10.1093/nar/gkn378
18. Picard F, Lebarbier E, Hoebeke M et al (2011) Joint segmentation, calling, and normalization of multiple cgh profiles. Biostatistics (Oxford, England) 12(3): 413-428. doi: kxq076 [pii] 10.1093/biostatistics/kxq076
19. Ragland BD, Bell WC, Lopez RR et al (2002) Cytogenetics and molecular biology of osteosarcoma. Lab Invest 82(4): 365-373
20. Sandberg AA, Bridge J.A. (2003) Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: Osteosarcoma and related tumors. Cancer Genet Cytogenet 145(1): 1-30
21. Bridge JA, Nelson M, Mccomb E et al (1997) Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. Cancer Genet Cytogenet 95(1): 74-87. doi: S0165460896003068 [pii]
22. Batanian JR, Cavalli LR, Aldosari NM et al (2002) Evaluation of paediatric osteosarcomas by classic cytogenetic and cgh analyses. Mol Pathol 55(6): 389-393
23. Forus A, Weghuis DO, Smeets D et al (1995) Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas. Genes Chromosomes Cancer 14(1): 15-21
24. Ozaki T, Schaefer KL, Wai D et al (2002) Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas. Int J Cancer 102(4): 355-365. doi: 10.1002/ijc.10709
25. Stock C, Kager L, Fink FM et al (2000) Chromosomal regions involved in the pathogenesis of osteosarcomas. Genes Chromosomes Cancer 28(3): 329-336
26. Tarkkanen M, Karhu R, Kallioniemi A et al (1995) Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res 55(6): 1334-1338
27. Tarkkanen M, Kiuru-Kuhlefelt S, Blomqvist C et al (1999) Clinical correlations of genetic changes by comparative genomic hybridization in ewing sarcoma and related tumors. Cancer Genet Cytogenet 114(1): 35-41. doi: S016546089900031X [pii]
28. Zielenska M, Bayani J, Pandita A et al (2001) Comparative genomic hybridization analysis identifies gains of 1p35 approximately p36 and chromosome 19 in osteosarcoma. Cancer Genet Cytogenet 130(1): 14-21
29. Hulsebos TJ, Bijleveld EH, Oskam NT et al (1997) Malignant astrocytoma-derived region of common amplification in chromosomal band 17p12 is frequently amplified in highgrade osteosarcomas. Genes Chromosomes Cancer 18(4): 279-285. doi: 10.1002/(SICI)1098-2264(199704)18:4<279::AID-GCC5>3.0.CO;2- Y [pii]
30. Atiye J, Wolf M, Kaur S et al (2005) Gene amplifications in osteosarcoma-cgh microarray analysis. Genes Chromosomes Cancer 42(2): 158-163. doi: 10.1002/gcc.20120
31. Man TK, Lu XY, Jaeweon K et al (2004) Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer 4: 45. doi: 10.1186/1471-2407-4-451471-2407-4-45 [pii]
32. Squire JA, Pei J, Marrano P et al (2003) High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of cgh analysis of cdna microarrays. Genes Chromosomes Cancer 38(3): 215-225
33. Zielenska M, Marrano P, Thorner P et al (2004) High-resolution cdna microarray cgh mapping of genomic imbalances in osteosar-coma using formalin-fixed paraffin-embedded tissue. Cytogenet Genome Res 107(1-2): 77-82
34. Lau CC, Harris CP, Lu XY et al (2004) Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer 39(1): 11-21. doi: 10.1002/gcc.10291
35. Bayani J, Zielenska M, Pandita A et al (2003) Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas. Genes Chromosomes Cancer 36(1): 7-16
36. Lengauer C, Kinzler KW, Vogelstein B. (1997) Genetic instability in colorectal cancers. Nature 386(6625): 623-627
37. Loeb LA (2001) A mutator phenotype in cancer. Cancer Res 61(8): 3230-3239
38. Gisselsson D, Bjork J, Hoglund M et al (2001) Abnormal nuclear shape in solid tumors reflects mitotic instability. Am J Pathol 158(1): 199-206. doi: S0002-9440(10)63958-2 [pii] 10.1016/S0002-9440(10)63958-2
39. Lim G, Karaskova J, Beheshti B et al (2005) An integrated mband and submegabase resolution tiling set (smrt) cgh array analysis of focal amplification, microdeletions, and ladder structures consistent with breakage-fusion-bridge cycle events in osteosarcoma. Genes Chromosomes Cancer 42(4): 392-403
40. Lim G, Karaskova J, Vukovic B et al (2004) Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line mg-63. Cancer Genet Cytogenet 153(2): 158-164
41. Selvarajah S, Yoshimoto M, Park PC et al (2006) The breakage-fusion- bridge (bfb) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma. Chromosoma 115(6): 459-467. doi: 10.1007/s00412-006-0074-4
42. Selvarajah S, Yoshimoto M, Maire G et al (2007) Identification of cryptic microaberrations in osteosarcoma by high-definition oligonucleotide array comparative genomic hybridization. Cancer Genet Cytogenet 179(1): 52-61. doi: S0165-4608(07)00492-X [pii] 10.1016/j.cancergencyto.2007.08.003
43. Tarkkanen M, Bohling T, Gamberi G et al (1998) Comparative genomic hybridization of low-grade central osteosarcoma. Mod Pathol 11(5): 421-426
44. Tarkkanen M, Elomaa I, Blomqvist C et al (1999) DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma. Int J Cancer 84(2): 114-121
45. Angstadt AY, Motsinger-Reif A, Thomas R et al (2011) Characterization of canine osteosarcoma by array comparative genomic hybridization and rt-qpcr: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart. Genes Chromosomes Cancer 50(11): 859-874. doi: 10.1002/gcc.20908
46. Dujardin F, Binh MB, Bouvier C et al (2011) Mdm2 and cdk4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol 24(5): 624-637. doi: modpathol2010229 [pii] 10.1038/modpathol.2010.229
47. Hattinger CM, Reverter-Branchat G, Remondini D et al (2003) Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques. Eur J Cell Biol 82(9): 483-493
48. Hattinger CM, Stoico G, Michelacci F et al (2009) Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines. Genes Chromosomes Cancer 48(4): 289-309. doi: 10.1002/gcc.20640
49. Kresse SH, Ohnstad HO, Paulsen EB et al (2009) Lsamp, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization. Genes Chromosomes Cancer 48(8): 679-693. doi: 10.1002/gcc.20675
50. Lockwood WW, Stack D, Morris T et al (2011) Cyclin e1 is amplified and overexpressed in osteosarcoma. J Mol Diagn 13(3): 289-296. doi: S1525-1578(11)00026-2 [pii] 10.1016/j.jmoldx.2010.11.020
51. Lu XY, Lu Y, Zhao YJ et al (2008) Cell cycle regulator gene cdc5l, a potential target for 6p12-p21 amplicon in osteosarcoma. Mol Cancer Res 6(6): 937-946. doi: 6/6/937 [pii] 10.1158/1541-7786.MCR-07-2115
52. Ma O, Cai WW, Zender L et al (2009) Mmp13, birc2 (ciap1), and birc3 (ciap2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression. Cancer Res 69(6): 2559-2567. doi: 0008-5472.CAN-08- 2929 [pii] 10.1158/0008-5472.CAN-08-2929
53. Pasic I, Shlien A, Durbin AD et al (2010) Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding rnas and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res 70(1): 160-171. doi: 0008-5472.CAN-09-1902 [pii] 10.1158/0008-5472.CAN-09-1902
54. Sadikovic B, Yoshimoto M, Al-Romaih K et al (2008) In vitro analysis of integrated global high-resolution DNA methylation profiling with genomic imbalance and gene expression in osteosarcoma. PLoS One 3(7): e2834. doi: 10.1371/journal.pone.0002834
55. Sadikovic B, Yoshimoto M, Chilton-Macneill S et al (2009) Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling. Hum Mol Genet 18(11): 1962-1975. doi: ddp117 [pii] 10.1093/hmg/ddp117
56. Thomas R, Wang HJ, Tsai PC et al (2009) Influence of genetic background on tumor karyotypes: Evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma. Chromosome Res 17(3): 365-377. doi: 10.1007/s10577-009-9028-z
57. Yang J, Cogdell D, Yang D et al (2010) Deletion of the wwox gene and frequent loss of its protein expression in human osteosarcoma. Cancer Lett 291(1): 31-38. doi: S0304-3835(09)00617-X [pii] 10.1016/j.canlet.2009.09.018
58. Yasuda T, Kanamori M, Nogami S et al (2009) Establishment of a new human osteosarcoma cell line, utos-1: cytogenetic characterization by array comparative genomic hybridization. J Exp Clin Cancer Res 28: 26. doi: 1756-9966-28-26 [pii] 10.1186/1756-9966-28-26
59. Benassi MS, Molendini L, Gamberi G et al (2001) Involvement of ink4a gene products in the pathogenesis and development of human osteosarcoma. Cancer 92(12): 3062-3067
60. Radig K, Schneider-Stock R, Oda Y et al (1996) Mutation spectrum of p53 gene in highly malignant human osteosarcomas. Gen Diagn Pathol 142(1): 25-32
61. Molendini L, Benassi MS, Magagnoli G et al (1998) Prognostic significance of cyclin expression in human osteosarcoma. Int J Oncol 12(5): 1007-1011
62. Radig K, Schneider-Stock R, Mittler U et al (1998) Genetic instability in osteoblastic tumors of the skeletal system. Pathol Res Pract 194(10): 669-677
63. Hansen MF (2002) Genetic and molecular aspects of osteosarcoma. J Musculoskelet Neuronal Interact 2(6): 554-560
64. Feugeas O, Guriec N, Babin-Boilletot A et al (1996) Loss of heterozygosity of the rb gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol 14(2): 467-472
65. Nielsen GP, Burns KL, Rosenberg AE et al (1998) Cdkn2a gene deletions and loss of p16 expression occur in osteosarcomas that lack rb alterations. Am J Pathol 153(1): 159-163. doi: S0002-9440(10)65556-3 [pii] 10.1016/S0002-9440(10) 65556-3
66. Levine AJ (1997) P53, the cellular gatekeeper for growth and division. Cell 88(3): 323-331. doi: S0092-8674(00)81871-1 [pii]
67. Ladanyi M, Cha C, Lewis R et al (1993) Mdm2 gene amplification in metastatic osteosarcoma. Cancer Res 53(1): 16-18
68. Maitra A, Roberts H, Weinberg AG et al (2001) Loss of p16(ink4a) expression correlates with decreased survival in pediatric osteosarcomas. Int J Cancer 95(1): 34-38. doi: 10.1002/1097-0215(20010120)95:1<34::AID- IJC1006>3.0.CO;2-V [pii]
69. Kruzelock RP, Murphy EC, Strong LC et al (1997) Localization of a novel tumor suppressor locus on human chromosome 3q important in osteosarcoma tumorigenesis. Cancer Res 57(1): 106-109
70. Gorlick R, Huvos AG, Heller G et al (1999) Expression of her2/erbb-2 correlates with survival in osteosarcoma. J Clin Oncol 17(9): 2781-2788
71. Onda M, Matsuda S, Higaki S et al (1996) Erbb-2 expression is correlated with poor prognosis for patients with osteosarcoma. Cancer 77(1): 71-78. doi: 10.1002/(SICI)1097-0142(19960101)77:1<71::AID-CNCR13>3.0.CO;2-5 [pii] 10.1002/(SICI)1097-0142(19960101)77:1<71::AID-CNCR13>3.0.CO;2-5
72. Guo W, Gorlick R, Ladanyi M et al (1999) Expression of bone morphogenetic proteins and receptors in sarcomas. Clin Orthop Relat Res 365: 175-183
73. Mohaghegh P, Hickson I.D. (2001) DNA heli-case deficiencies associated with cancer predisposition and premature ageing disorders. Hum Mol Genet 10(7): 741-746
74. Wang LL, Gannavarapu A, Kozinetz CA et al (2003) Association between osteosarcoma and deleterious mutations in the recql4 gene in rothmund-thomson syndrome. J Natl Cancer Inst 95(9): 669-674
75. Tiet TD, Alman B.A. (2003) Developmental pathways in musculoskeletal neoplasia: Involvement of the indian hedgehog-parathyroid hormone-related protein pathway. Pediatr Res 53(4): 539-543. doi: 10.1203/01.PDR.0000054688. 93486.1801.PDR.0000054688.93486.18 [pii]
76. Wu JX, Carpenter PM, Gresens C et al (1990) The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas. Oncogene 5(7): 989-1000
77. Franchi A, Arganini L, Baroni G et al (1998) Expression of transforming growth factor beta isoforms in osteosarcoma variants: Association of tgf beta 1 with high-grade osteosarcomas. J Pathol 185(3): 284-289. doi: 10.1002/(SICI)1096-9896(199807)185:3<284::AID-PATH94>3.0.CO;2-Z [pii] 10.1002/(SICI)1096-9896(199807)185:3<284::AID-PATH94>3.0.CO;2-Z
78. Chan HS, Grogan TM, Haddad G et al (1997) P-glycoprotein expression: Critical determinant in the response to osteosarcoma chemotherapy. J Natl Cancer Inst 89(22): 1706-1715
79. Baldini N, Scotlandi K, Serra M et al (1999) P-glycoprotein expression in osteosarcoma: a basis for risk-adapted adjuvant chemotherapy. J Orthop Res 17(5): 629-632. doi: 10.1002/jor.1100170502
80. Dalla-Torre C.A., Yoshimoto M, Lee CH et al (2006) Effects of thbs3, sparc and spp 1 expression on biological behavior and survival in patients with osteosarcoma. BMC Cancer 6: 237. doi: 1471-2407-6-237 [pii] 10.1186/1471-2407-6- 237
81. Dalla-Torre C.A., De Toledo SR, Yoshimoto M et al (2007) Expression of major vault protein gene in osteosarcoma patients. J Orthop Res 25(7): 958-963. doi: 10.1002/jor.20371
82. Sadikovic B, Al-Romaih K, Squire JA et al (2008) Cause and consequences of genetic and epigenetic alterations in human cancer. Curr Genomics 9(6): 394-408. doi: 10.2174/138920208785699580
83. Sadikovic B, Thorner P, Chilton-Macneill S et al (2010) Expression analysis of genes associated with human osteosarcoma tumors shows correlation of runx2 overexpression with poor response to chemotherapy. BMC Cancer 10: 202. doi: 1471-2407-10-202 [pii] 10.1186/1471-2407-10-202